COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02813096
Recruitment Status : Unknown
Verified October 2016 by Jiazhou Ye, Guangxi Medical University.
Recruitment status was:  Not yet recruiting
First Posted : June 24, 2016
Last Update Posted : October 25, 2016
Information provided by (Responsible Party):
Jiazhou Ye, Guangxi Medical University

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : July 2018